No black box warning on record for Gavilyte-H And Bisacodyl

As of the latest FDA labeling reviewed, Gavilyte-H And Bisacodyl (POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL DELAYED-RELEASE TABLET) does not carry a black box warning. Standard warnings and precautions still apply — see the full Gavilyte-H And Bisacodyl medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Risk of fluid and electrolyte abnormalities, arrhythmias, seizures and renal impairment – assess concurrent medications and consider testing in some patients ( 5.1 , 5.2 , 5.3 , 5.4 ) Patients with renal impairment – use caution, ensure adequate hydration and consider testing ( 5.3 ) Ischemic colitis has been reported ( 5.5 ) Suspected GI obstruction or perforation – rul

No black box warning on record for Gavilyte-H And Bisacodyl

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Risk of fluid and electrolyte abnormalities, arrhythmias, seizures and renal impairment – assess concurrent medications and consider testing in some patients ( 5.1 , 5.2 , 5.3 , 5.4 ) Patients with renal impairment – use caution, ensure adequate hydration and consider testing ( 5.3 ) Ischemic colitis has been reported ( 5.5 ) Suspected GI obstruction or perforation – rul

Gavilyte-H And Bisacodyl Black Box Warning

No black box warning on record for Gavilyte-H And Bisacodyl

Other warnings & precautions

Gavilyte-H And Bisacodyl Black Box Warning

No black box warning on record for Gavilyte-H And Bisacodyl

Other warnings & precautions